Literature DB >> 30218655

Development of Medication-Related Osteonecrosis of the Jaw After Extraction of Teeth With Experimental Periapical Disease.

Danny Hadaya1, Akrivoula Soundia1, Ioannis Gkouveris2, Sarah M Dry3, Tara L Aghaloo4, Sotirios Tetradis5.   

Abstract

PURPOSE: Medication-related osteonecrosis of the jaw (MRONJ) is a rare but severe side effect of antiresorptive medications. Most animal models use tooth extraction as an instigating local factor to induce MRONJ, with varied results. However, these teeth are healthy and absent of dental disease, a rare finding that does not reflect clinical practices. The authors hypothesized that extraction of teeth with periapical inflammation would lead to MRONJ in rats treated with high-dose bisphosphonates.
MATERIALS AND METHODS: Rats were pretreated with zoledronic acid (ZA) for 1 week. Pulp exposure (PE) was established by exposing the pulpal chamber of the first and second molars. Experimental periapical disease (EPD) was induced by PE and bacterial inoculation into pulp chambers of the first and second mandibular molars. The mandibular molars were extracted 4 weeks after PE or EPD, and animals were euthanized 4 weeks after tooth extraction. Extraction sockets were assessed clinically, radiographically, and histologically.
RESULTS: Clinically, radiographically, and histologically, socket healing was observed in all vehicle-treated animals and in ZA-treated animals after extraction of healthy teeth or teeth with PE. In contrast, bone exposure, lack of socket healing, and osteonecrosis were present in most ZA-treated animals after extraction of teeth with EPD. Bacterial presence was noted in areas of osteonecrotic alveolar bone.
CONCLUSION: These data support a synergistic contribution of severe dental disease and tooth extraction to MRONJ pathogenesis. Importantly, this model is amenable to manipulation of methodologic conditions for the dissection of parameters involved in MRONJ pathogenesis.
Copyright © 2018 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30218655      PMCID: PMC6312738          DOI: 10.1016/j.joms.2018.08.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  8 in total

1.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

2.  Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).

Authors:  Ioannis Gkouveris; Danny Hadaya; Akrivoula Soundia; Olga Bezouglaia; Yee Chau; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  Bone       Date:  2019-04-03       Impact factor: 4.398

3.  Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.

Authors:  Ioannis Gkouveris; Danny Hadaya; Naseim Elzakra; Akrivoula Soundia; Olga Bezouglaia; Sarah M Dry; Flavia Pirih; Tara Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2022-07-11       Impact factor: 6.390

Review 4.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

5.  Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden.

Authors:  D Hadaya; A Soundia; I Gkouveris; O Bezouglaia; S M Dry; F Q Pirih; T L Aghaloo; S Tetradis
Journal:  J Dent Res       Date:  2021-01-21       Impact factor: 8.924

6.  Porphyromonas gingivalis Induces Bisphosphonate-Related Osteonecrosis of the Femur in Mice.

Authors:  Shuxuan Wu; Feng Li; Jingjing Tan; Xiaoling Ye; Yushi Le; Nianke Liu; Vincent Everts; Qilong Wan
Journal:  Front Cell Infect Microbiol       Date:  2022-06-22       Impact factor: 6.073

Review 7.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

8.  The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw.

Authors:  Sotirios Tetradis; Christos Perisanidis; Nikolaos G Nikitakis; Polytimi Paschalidi; Ioannis Gkouveris; Akrivoula Soundia; Evangelos Kalfarentzos; Emmanouil Vardas; Maria Georgaki; Georgios Kostakis; Boban M Erovic
Journal:  Clin Oral Investig       Date:  2020-09-22       Impact factor: 3.573

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.